Status:
RECRUITING
An Evaluation of the KCCQ Score in Predicting Cardiovascular Risk in Dialysis Patients
Lead Sponsor:
Shenzhen Second People's Hospital
Conditions:
Chronic Kidney Disease Stage 5
Dialysis
Eligibility:
All Genders
18+ years
Brief Summary
Cardiovascular Disease (CVD) is the main complication and the most important cause of death in CKD patients. As the disease progresses, the incidence of cardiovascular disease in CKD patients graduall...
Detailed Description
Investigators will apply the KCCQ to maintenance dialysis patients and statistically analyze baseline KCCQ scores and changing trends to investigate whether they are associated with the occurrence of ...
Eligibility Criteria
Inclusion
- Age 18 or older with no restrictions on gender or ethnicity;
- All enrolled patients meet the diagnostic criteria for CKD stage 5 according to the KDOQI guidelines of the National Kidney Foundation;
- Newly diagnosed uremia patients planning to start maintenance dialysis (hemodialysis or peritoneal dialysis), as well as patients currently undergoing maintenance dialysis treatment (hemodialysis or peritoneal dialysis);
- Clear contact information is available to reach patients or family members for follow-up;
- Signed informed consent and ability to complete the KCCQ.
Exclusion
- Patients with acute kidney injury from various causes;
- Patients with severe mental illnesses that affect their ability to complete questionnaires;
- Patients who have had acute myocardial infarction, coronary artery stent implantation, coronary artery bypass grafting (CABG) or pacemaker implantation within the past three months;
- Patients with special types of heart disease, including cardiac amyloidosis, congenital heart disease and pericardial diseases;
- Patients with chronic lung diseases;
- Patients with serious underlying conditions such as severe infections, tumors or severe liver diseases;
- Patients scheduled for kidney transplantation.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT06542016
Start Date
July 1 2024
End Date
July 1 2026
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Shenzhen
Guangdong, Guangdong, China, 518000